Holen Sie sich die Stockscreener-App
4.055
1.67%
-0.145
Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten
enGene Holdings CMO Resignation Announced - TipRanks
enGene (ENGN) CMO Raj Pruthi Steps Down | ENGN Stock News - GuruFocus
enGene CMO Dr. Raj Pruthi to step down mid-June By Investing.com - Investing.com Australia
enGene Announces the Resignation of its Chief Medical Officer - Business Wire
enGene to Present at the Jefferies Global Healthcare Conference - BioSpace
enGene appoints new Chief Global Commercialization Officer By Investing.com - Investing.com South Africa
enGene appoints new Chief Global Commercialization Officer - Investing.com Australia
enGene (ENGN) Appoints Amy Pott as New Chief Global Commercialization Officer | ENGN Stock News - GuruFocus
EnGene Names Amy Pott As Chief Global Commercialization Officer - marketscreener.com
enGene Names Amy Pott as Chief Global Commercialization Officer - Business Wire
When (ENGN) Moves Investors should Listen - news.stocktradersdaily.com
Head-To-Head Review: enGene (NASDAQ:ENGN) vs. ImmunityBio (NASDAQ:IBRX) - Defense World
Where are the Opportunities in (ENGN) - news.stocktradersdaily.com
Is enGene Holdings (NASDAQ:ENGN) Using Too Much Debt? - simplywall.st
(ENGN) Trading Signals - news.stocktradersdaily.com
Citizens JMP reiterates Engene stock with $18 target By Investing.com - Investing.com Nigeria
Citizens JMP reiterates Engene stock with $18 target - Investing.com
enGene to Participate in Upcoming Investor Conferences - Yahoo Finance
enGene to Participate in Upcoming May 2025 Investor Conferences - BioSpace
enGene Holdings Inc.'s (NASDAQ:ENGN) largest shareholders are private equity firms with 38% ownership, institutions own 35% - Yahoo Finance
Is enGene Holdings Inc. (ENGN) the Best Canadian Penny Stock to Invest in Now? - Insider Monkey
(ENGN) Technical Data - news.stocktradersdaily.com
enGene (NASDAQ:ENGN) & Innate Pharma (OTCMKTS:IPHYF) Head-To-Head Survey - Defense World
enGene Holdings Inc. (NASDAQ:ENGN) Receives Average Rating of “Buy” from Analysts - Defense World
Trend Tracker for (ENGN) - news.stocktradersdaily.com
Engene Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
enGene Expands Team with New Hires, Grants 144,650 Shares in Stock Options - Stock Titan
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Strategic Oncology Updates Coming: enGene CEO Headlines Stifel Healthcare Forum - Stock Titan
enGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum - Business Wire
How the (ENGN) price action is used to our Advantage - news.stocktradersdaily.com
Promising Trajectory and Strong Financial Position Justify Buy Rating for enGene Holdings - TipRanks
enGene Holdings Insider Ups Holding During Year - Yahoo Finance
enGene Holdings Inc.'s (NASDAQ:ENGN) market cap dropped US$33m last week; individual investors who hold 38% were hit as were institutions - Simply Wall St
enGene’s (ENGN) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
enGene (NASDAQ:ENGN) Price Target Lowered to $34.00 at Morgan Stanley - Defense World
Engene stock holds Buy rating, $25 target from H.C. Wainwright - Investing.com
Engene stock holds Buy rating, $25 target from H.C. Wainwright By Investing.com - Investing.com South Africa
enGene Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace
enGene Holdings Inc. SEC 10-Q Report - TradingView
enGene Reports Q1 Results: Strong Cash Position Funds Global Trial Expansion - StockTitan
Trading (ENGN) With Integrated Risk Controls - Stock Traders Daily
enGene to Participate in the Leerink Partners Global Healthcare Conference - Business Wire
Lumira Ventures Portfolio Company enGene (Nasdaq:ENGN) Debuts as Publicly Traded Genetic Medicines Company - ACCESS Newswire
enGene Holdings Inc.: Unknown Company Which Looks Like A Catch (NASDAQ:ENGN) - Seeking Alpha
Financial Contrast: enGene (NASDAQ:ENGN) versus iTeos Therapeutics (NASDAQ:ITOS) - Defense World
(ENGN) On The My Stocks Page - Stock Traders Daily
Vontobel Holding Ltd. Makes New $69,000 Investment in enGene Holdings Inc. (NASDAQ:ENGN) - Defense World
enGene Holdings Inc. (NASDAQ:ENGN) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
enGene (NASDAQ:ENGN) Coverage Initiated at Piper Sandler - Armenian Reporter
enGene Holdings GAAP EPS of -$0.38 - MSN
New Strong Buy Stocks for February 19th - Zacks Investment Research
enGene (NASDAQ:ENGN) Now Covered by Piper Sandler - Defense World
Best Momentum Stocks to Buy for February 19th - Yahoo Finance
enGene Holdings Inc. (NASDAQ:ENGN) Given Average Rating of “Buy” by Brokerages - Defense World
Piper Sandler sets $26 target on Engene shares with Overweight rating - Investing.com Australia
This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Buy Rating for enGene Holdings: Strategic Positioning and Growth Potential in NMIBC Market - TipRanks
Piper Sandler Initiates Coverage on enGene Holdings With Overweight Rating, $26 Price Target - Marketscreener.com
Piper Sandler sets $26 target on Engene shares with Overweight rating By Investing.com - Investing.com South Africa
0.87%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):